Wire · opportunities
Rare Brain Disorder Gets Its First FDA Drug Approval
◆ Sectors
Biotech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 4 September 2026 · Fusion42 review
The FDA has approved zilganersen (Zanvastro), the first drug for treating Alexander disease, a rare brain disorder caused by protein buildup.
This Wire brief sits within Fusion42's coverage of Biotech, and 9 sources have reported it between 3 Sep 2026 and 4 Sep 2026.
◆ ◆ The Wire takeaway
You can now develop or reposition treatments for Alexander disease with a clear regulatory precedent in the US. This approval opens the door to commercialising therapies for rare brain disorders with targeted protein mechanisms.
◆ Coverage
9 sources · first reported 3 Sep 2026 · latest 4 Sep 2026
◆ Related on Wire
◆ Topics
Biotechrare-diseaseFDA-approvalneurologydrug-approval